[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:poorly-differentiated-thyroid-gland-carcinoma":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Poorly Differentiated Thyroid Gland Carcinoma",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06959641","XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer",[11],"Phase 2","RECRUITING","2026-08-26T02:18:26.932189Z","2026-07-05T05:32:16.722331Z",[],[]]